Internal Medicine · Orange Park, FL
NPI
1346240504
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
165 Wells Rd
Orange Park, FL, 32073
Phone (904) 264-3111
Groups this clinician bills Medicare through
Medicare paid, 2024
$601K
8,700 services
Medicare patients, 2024
745
Average age 78
Drug cost, 2024
$1.8M
22,947 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rajesh K Vishen was code 99308 (snf e&m), 3,444 times for 454 patients. In total Rajesh K Vishen billed 8,700 services in 23 codes, and Medicare paid $601K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-12-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99308 SNF E&M | Office | 3,444 | 454 | $57.22 | $197K |
| 99308 SNF E&M | Facility | 1,914 | 315 | $54.84 | $105K |
| 99309 SNF E&M | Office | 1,480 | 398 | $82.69 | $122K |
| 99309 SNF E&M | Facility | 699 | 254 | $82.40 | $58K |
| 99306 SNF E&M | Office | 341 | 320 | $140.12 | $48K |
| 99232 Hospital E&M - Subsequent | Facility | 176 | 24 | $61.54 | $11K |
| 99316 SNF E&M | Office | 163 | 153 | $100.86 | $16K |
| 99233 Hospital E&M - Subsequent | Facility | 133 | 22 | $92.58 | $12K |
| 99310 SNF E&M | Office | 112 | 75 | $117.23 | $13K |
| 99315 SNF E&M | Office | 60 | 57 | $63.24 | $3,794 |
| G0182 Physician supervision of a patient under a medicare-approved hospice (patient not present) requiring complex and multidisciplinary care modalities involving regular physician development and/or revision of care plans, review of subsequent reports of patien | Office | 26 | 25 | $79.71 | $2,072 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 22 | 21 | $41.01 | $902 |
| 99310 SNF E&M | Facility | 21 | 20 | $114.48 | $2,404 |
| 99304 SNF E&M | Facility | 18 | 17 | $55.32 | $996 |
| 99304 SNF E&M | Office | 17 | 17 | $62.49 | $1,062 |
By year: 2022 $195K for 2,744 services; 2023 $473K for 6,417 services; 2024 $601K for 8,700 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82947 Clinical Chemistry | 16 | 12 | $3.85 | $61.6 |
Medicare prescription drug claims, 2024
In 2024, the drug Rajesh K Vishen prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,266 prescriptions and refills. In total Rajesh K Vishen wrote 22,947 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,266 | 1,308 | 244 | $23K |
| Eliquis Apixaban | 940 | 940 | 135 | $292K |
| Gabapentin Generic | 871 | 877 | 177 | $21K |
| Levothyroxine Sodium Generic | 760 | 800 | 149 | $11K |
| Amlodipine Besylate Generic | 675 | 677 | 146 | $7,207 |
| Sertraline Hcl Generic | 634 | 638 | 133 | $9,546 |
| Trazodone Hcl Generic | 593 | 593 | 129 | $8,232 |
| Potassium Chloride Generic | 542 | 545 | 126 | $11K |
| Metoprolol Tartrate Generic | 523 | 548 | 119 | $5,706 |
| Lisinopril Generic | 509 | 553 | 103 | $6,735 |
| Losartan Potassium Generic | 475 | 494 | 116 | $7,192 |
| Carvedilol Generic | 425 | 452 | 89 | $5,534 |
| Tamsulosin Hcl Generic | 397 | 427 | 95 | $7,559 |
| Mirtazapine Generic | 387 | 387 | 100 | $13K |
| Clopidogrel Clopidogrel Bisulfate | 371 | 394 | 83 | $5,952 |
Brand drugs: 3,764 claims; generic drugs: 19,102 claims; opioid claims: 23.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Rajesh K Vishen were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.